XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2022   47,269,446      
Beginning balance at Dec. 31, 2022 $ 1,892,611 $ 473 $ 439,681 $ 1,537,830 $ (85,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (7,627)     (7,627)  
Other comprehensive loss, net of tax (benefit) expense 4,037       4,037
Issuance of restricted stock, net (in shares)   16,647      
Issuance of restricted stock, net (2,875)   (3,336) 461  
Share-based compensation 8,402   8,402    
Other, net 67   66 1  
Ending balance (in shares) at Mar. 31, 2023   47,286,093      
Ending balance at Mar. 31, 2023 $ 1,894,615 $ 473 444,813 1,530,665 (81,336)
Beginning balance (in shares) at Dec. 31, 2023 46,078,464 46,078,464      
Beginning balance at Dec. 31, 2023 $ 1,892,998 $ 461 472,201 1,491,956 (71,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 10,627     10,627  
Other comprehensive loss, net of tax (benefit) expense (6,593)       (6,593)
Issuance of restricted stock, net (in shares)   56,244      
Issuance of restricted stock, net (3,923)   (5,152) 1,229  
Share-based compensation 8,872   8,872    
Other, net $ 31   5 26  
Ending balance (in shares) at Mar. 31, 2024 46,134,708 46,134,708      
Ending balance at Mar. 31, 2024 $ 1,902,012 $ 461 $ 475,926 $ 1,503,838 $ (78,213)